Cite

    Martin Fisher et al.. “Safety and efficacy of lopinavir/ritonavir-containing antiretroviral therapy in patients aged <50 versus ≥50 years from randomized trials.” Future virology, vol. 9, 2014, pp. 351–362. http://access.bl.uk/ark:/81055/vdc_100142011360.0x00000f